Suppr超能文献

保乳手术后局部乳房照射的围手术期组织间近距离放疗的长期局部控制和美容效果

Long-term local control and cosmesis of perioperative interstitial brachytherapy for partial breast irradiation following breast-conserving surgery.

作者信息

Sato Kazuhiko, Fuchikami Hiromi, Takeda Naoko, Natsume Nana, Kato Masahiro

机构信息

Department of Breast Oncology, Tokyo-West Tokushukai Hospital, Tokyo, Japan.

Department of Radiation Oncology, Tokyo-West Tokushukai Hospital, Tokyo, Japan.

出版信息

Breast Cancer. 2025 Mar;32(2):447-455. doi: 10.1007/s12282-025-01674-x. Epub 2025 Feb 5.

Abstract

PURPOSE

Multicatheter interstitial brachytherapy (MIB) is an established technique of partial breast irradiation (PBI). However, postoperative catheter implant is an invasive, inconvenient, and skillful procedure. In this study, local control and cosmesis of perioperative interstitial brachytherapy (PIB) by intraoperative catheter implant were evaluated by comparing with those of whole breast irradiation (WBI) following breast-conserving surgery (BCS).

METHODS

Between October 2007 and August 2019, consequent patients who underwent either PIB or WBI following BCS were included. In general, additional indications for PIB to WBI included age ≥ 40 years, tumor ≤ 3 cm, and pN0 or pNmi. WBI was initiated with a total dose of 50 Gy in 25 fractions, whereas PBI was delivered immediately following BCS at 32 Gy in eight fractions. Local recurrence (LR) was the primary endpoint, and subjective and objective cosmetic outcomes at 5 years using the Harvard Cosmesis Scale and BCCT.core software, respectively, were the secondary endpoints.

RESULTS

During the 10-year follow-up, the crude rate of LR was 3.8% (95% confidence interval [CI] 2.3-5.4) in 577 patients receiving PIB and 3.3% (95% CI 1.1-5.6) in 241 patients receiving WBI (P = 0.73). The 5- and 10-year LR-free survival rates in the PBI and WBI cohorts were 97.9% versus 97.9% and 95.4% versus 96.8%, respectively (P = 0.64). Multivariate analysis selected age < 50 years as an independent risk factor for LR. Excellent or good cosmesis in the PBI and WBI cohorts assessed by subjective and objective measures was 89.5% versus 84.5% (P = 0.26) and 83.7% versus 68.1% (P < 0.005), respectively.

CONCLUSIONS

Although this study was based on a retrospective chart review in a single institution, the largest series of data with a long follow-up suggested that acceptable local tumor control and cosmesis were achieved following PIB compared with WBI.

摘要

目的

多导管组织间近距离放射治疗(MIB)是一种成熟的部分乳腺照射(PBI)技术。然而,术后导管植入是一种侵入性、不方便且需要技巧的操作。在本研究中,通过与保乳手术(BCS)后全乳照射(WBI)的局部控制和美容效果进行比较,评估术中导管植入的围手术期组织间近距离放射治疗(PIB)的效果。

方法

纳入2007年10月至2019年8月期间接受BCS后PIB或WBI的连续患者。一般来说,PIB相对于WBI的额外适应症包括年龄≥40岁、肿瘤≤3 cm以及pN0或pNmi。WBI开始时总剂量为50 Gy,分25次给予,而PIB在BCS后立即给予,剂量为32 Gy,分8次给予。局部复发(LR)是主要终点,分别使用哈佛美容量表和BCCT.core软件评估5年时的主观和客观美容效果是次要终点。

结果

在10年的随访中,577例接受PIB的患者中LR的粗发生率为3.8%(95%置信区间[CI] 2.3 - 5.4),241例接受WBI的患者中为3.3%(95% CI 1.1 - 5.6)(P = 0.73)。PIB组和WBI组的5年和10年无LR生存率分别为97.9%对97.9%和95.4%对96.8%(P = 0.64)。多因素分析选择年龄<50岁作为LR的独立危险因素。通过主观和客观测量评估,PIB组和WBI组的美容效果为优或良的比例分别为89.5%对84.5%(P = 0.26)和83.7%对68.1%(P < 0.005)。

结论

尽管本研究基于单一机构的回顾性病历审查,但这一最大规模且随访时间长的系列数据表明,与WBI相比,PIB后可实现可接受的局部肿瘤控制和美容效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验